Advertisement
Advertisement

Indicator

Free Access

Pay per View

Partial Free Access

Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 2 29 87 63
Fax: +49 (0)711 - 2 29 87 65
send an Email


Archive

Genetic variation in Fcγ receptor IIa protects against advanced peripheral atherosclerosis The Rotterdam Study

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

Pharmacotherapy in Cardiovascular Disease

DOI: http://dx.doi.org/10.1160/TH04-05-0268
Issue: 2004: 92/6 (Dec) pp. 1170-1456
Pages: 1273-1276

Genetic variation in Fcγ receptor IIa protects against advanced peripheral atherosclerosis The Rotterdam Study

Irene M. van der Meer (1), Jacqueline C. M.Witteman (1),Albert Hofman (1), Cornelis Kluft (2), Moniek P. M. de Maat (2)
(1) Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam,The Netherlands (2) Gaubius Laboratory, TNO-Prevention and Health, Leiden, The Netherlands

Summary

Immune processes play a substantial role in atherosclerotic disease. The role in atherosclerosis of Fcγ receptor IIa (Fc?RIIa), a receptor for immunoglobulin G and for the inflammatory mediator C-reactive protein, is not yet clear. Since the R/H131 polymorphism in the FcγRIIa gene strongly influences binding to FcγRIIa,we investigated the association of the R/H131 polymorphism with advanced peripheral atherosclerosis. Within the Rotterdam Study, a population-based cohort study, we determined Fc?RIIa genotype in 430 subjects with advanced peripheral atherosclerosis as indicated by the ankle-arm index, and 411 controls. Heterozygous and homozygous carriers of the H131 allele were protected against advanced peripheral atherosclerosis (age- and gender-adjusted odds ratio (OR) 0.77 (0.54-1.12) and 0.65 (0.44-0.98), respectively, P trend=0.04). This effect was most pronounced in subjects with modestly elevated levels of inflammation as indicated by the leukocyte count (OR 0.52 (0.29-0.93) and 0.45 (0.23-0.86), for heterozygotes and H131 homozygotes, respectively; P trend=0.02). This is the first study showing that the H131 allele of Fc?RIIa protects against advanced peripheral atherosclerosis.

DOI

http://dx.doi.org/10.1160/TH04-05-0268